Search

everythinglearnresearchcommunity

for

Search:↓

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

A Chinese boy's scalp infection from a guinea pig was cured with medication.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Skin reactions from cancer treatments might predict how well the treatments work.

Itraconazole may cause low platelet and white blood cell counts.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

CMV infection increases the risk of GvHD after bone marrow transplants.

Cyclophosphamide severely damages the intestinal lining in rats.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.